Literature DB >> 12847247

Innate immunity together with duration of antigen persistence regulate effector T cell induction.

Tazio Storni1, Christiane Ruedl, Wolfgang A Renner, Martin F Bachmann.   

Abstract

Proliferation of T cells is important for the expansion of specific T cell clones during immune responses. In addition, for the establishment of protective immunity against viruses, bacteria, and tumors, the expanded T cells must differentiate into effector T cells. Here we show that effector T cell generation is driven by activation of APCs and duration of antigenic stimulation. Adoptively transferred TCR-transgenic T cells extensively proliferated upon immunization. However, these T cells failed to differentiate into effector cells and died within 1 wk after immunization unless antigenic peptides persisted for >1 day or were presented by activated APCs. The induction of protective immunity in a nontransgenic system was more stringent, since activation of APCs or prolonged Ag persistence alone was not sufficient to drive immunity. In contrast, Ag had to be presented for several days by activated APCs to trigger protective T cell responses. Thus, activation of APCs and duration of Ag presentation together regulate the induction of protective T cell responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12847247     DOI: 10.4049/jimmunol.171.2.795

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Virus-like particles as carriers for T-cell epitopes: limited inhibition of T-cell priming by carrier-specific antibodies.

Authors:  Christiane Ruedl; Katrin Schwarz; Andrea Jegerlehner; Tazio Storni; Vania Manolova; Martin F Bachmann
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 2.  New approaches to design HIV-1 T-cell vaccines.

Authors:  Hélène Perrin; Glenda Canderan; Rafick-Pierre Sékaly; Lydie Trautmann
Journal:  Curr Opin HIV AIDS       Date:  2010-09       Impact factor: 4.283

3.  Studies on mRNA electroporation of immature and mature dendritic cells: effects on their immunogenic potential.

Authors:  Ozcan Met; Jens Eriksen; Inge Marie Svane
Journal:  Mol Biotechnol       Date:  2008-06-10       Impact factor: 2.695

Review 4.  Recombinant lentivector as a genetic immunization vehicle for antitumor immunity.

Authors:  Yukai He; David Munn; Louis D Falo
Journal:  Expert Rev Vaccines       Date:  2007-12       Impact factor: 5.217

5.  Antigen-induced Erk1/2 activation regulates Ets-1-mediated sensitization of CD8+ T cells for IL-12 responses.

Authors:  Qingsheng Li; Cheryl Eppolito; Kunle Odunsi; Protul A Shrikant
Journal:  J Leukoc Biol       Date:  2009-10-20       Impact factor: 4.962

6.  Linkage between Anaplasma marginale outer membrane proteins enhances immunogenicity but is not required for protection from challenge.

Authors:  Susan M Noh; Joshua E Turse; Wendy C Brown; Junzo Norimine; Guy H Palmer
Journal:  Clin Vaccine Immunol       Date:  2013-02-27

7.  Blocking Virus Replication during Acute Murine Cytomegalovirus Infection Paradoxically Prolongs Antigen Presentation and Increases the CD8+ T Cell Response by Preventing Type I IFN-Dependent Depletion of Dendritic Cells.

Authors:  Christopher P Loo; Christopher M Snyder; Ann B Hill
Journal:  J Immunol       Date:  2016-11-21       Impact factor: 5.422

8.  Epigenetic potentiation of NY-ESO-1 vaccine therapy in human ovarian cancer.

Authors:  Kunle Odunsi; Junko Matsuzaki; Smitha R James; Paulette Mhawech-Fauceglia; Takemasa Tsuji; Austin Miller; Wa Zhang; Stacey N Akers; Elizabeth A Griffiths; Anthony Miliotto; Amy Beck; Carl A Batt; Gerd Ritter; Shashikant Lele; Sacha Gnjatic; Adam R Karpf
Journal:  Cancer Immunol Res       Date:  2014-01       Impact factor: 11.151

9.  Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity.

Authors:  Peter B Stranges; Jessica Watson; Cristie J Cooper; Caroline-Morgane Choisy-Rossi; Austin C Stonebraker; Ryan A Beighton; Heather Hartig; John P Sundberg; Stein Servick; Gunnar Kaufmann; Pamela J Fink; Alexander V Chervonsky
Journal:  Immunity       Date:  2007-05       Impact factor: 31.745

10.  Gender differences in human immunodeficiency virus type 1-specific CD8 responses in the reproductive tract and colon following nasal peptide priming and modified vaccinia virus Ankara boosting.

Authors:  James W Peacock; Sushila K Nordone; Shawn S Jackson; Hua-Xin Liao; Norman L Letvin; Alicia Gomez Yafal; Linda Gritz; Gail P Mazzara; Barton F Haynes; Herman F Staats
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.